These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4006368)

  • 1. Pregnancy-induced increase in metoprolol metabolism.
    Högstedt S; Lindberg B; Peng DR; Regårdh CG; Rane A
    Clin Pharmacol Ther; 1985 Jun; 37(6):688-92. PubMed ID: 4006368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate.
    Lindeberg S; Sandström B; Lundborg P; Regårdh CG
    Acta Obstet Gynecol Scand Suppl; 1984; 118():61-4. PubMed ID: 6587729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol and metoprolol. A comparison of their excretion into human breast milk.
    Kulas J; Lunell NO; Rosing U; Stéen B; Rane A
    Acta Obstet Gynecol Scand Suppl; 1984; 118():65-9. PubMed ID: 6587730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women.
    Lindeberg S; Holm B; Lundborg P; Regårdh CG; Sandström B
    Eur J Clin Pharmacol; 1988; 35(2):131-5. PubMed ID: 3191932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oral clearance of metoprolol in pregnancy.
    Högstedt S; Lindberg B; Rane A
    Eur J Clin Pharmacol; 1983; 24(2):217-20. PubMed ID: 6840170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism.
    Högstedt S; Lindberg BS; Regårdh CG; Moström U; Rane A
    Pharmacol Toxicol; 1990 Jan; 66(1):32-6. PubMed ID: 2308905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of the adrenergic blocker metoprolol and its metabolite OH-metoprolol in maternal plasma, amniotic fluid and capillary blood of the neonate.
    Lindeberg S; Lundborg P; Regårdh CG; Sandström B
    Eur J Clin Pharmacol; 1987; 33(4):363-8. PubMed ID: 3443141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.
    Oumachigui A; Verghese M; Balachander J
    Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of metoprolol in the newborn.
    Lundborg P; Agren G; Ervik M; Lindeberg S; Sandstrom B
    Br J Clin Pharmacol; 1981 Oct; 12(4):598-600. PubMed ID: 7295496
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial.
    Jannet D; Carbonne B; Sebban E; Milliez J
    Obstet Gynecol; 1994 Sep; 84(3):354-9. PubMed ID: 8058230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of the adrenergic blocker metoprolol in the late pregnant women, the amniotic fluid, the cord blood and the neonate.
    Sandström B; Lindeberg S; Lundborg P; Regårdh CG
    Clin Exp Hypertens B; 1983; 2(1):75-82. PubMed ID: 6135523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
    Lecaillon JB; Massias P; Schoeller JP; Abadie F
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.
    Godbillon J; Evard D; Vidon N; Duval M; Schoeller JP; Bernier JJ; Hirtz J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):113S-118S. PubMed ID: 4005112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy.
    Wichman K; Rydén G; Karlberg BE
    Scand J Clin Lab Invest Suppl; 1984; 169():90-5. PubMed ID: 6387888
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of age on the pharmacokinetics of metoprolol and its metabolites.
    Quarterman CP; Kendall MJ; Jack DB
    Br J Clin Pharmacol; 1981 Mar; 11(3):287-94. PubMed ID: 7213530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.
    Evard D; Vidon N; Godbillon J; Bovet M; Duval M; Schoeller JP; Bernier JJ; Hirtz J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):119S-125S. PubMed ID: 4005113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
    Rigby JW; Scott AK; Hawksworth GM; Petrie JC
    Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.
    Regårdh CG; Landahl S; Larsson M; Lundborg P; Steen B; Hoffmann KJ; Lagerström PO
    Eur J Clin Pharmacol; 1983; 24(2):221-6. PubMed ID: 6840171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of cefoxitin in postpartum normotensive and pregnancy-induced hypertensive patients.
    Gonik B; Cotton D; Feldman S; Cleary TG; Pickering LK
    Am J Obstet Gynecol; 1984 Apr; 148(8):1088-91. PubMed ID: 6711643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.